Skip to main content

Remote Job Finders (RJF)

H2 2025 catalysts to watch, biopharma implications of President Trump’s tax law, KalVista’s new hereditary angioedema drug that Marty Makary reportedly tried to reject, another lawsuit aimed at Health Secretary Robert F. Kennedy Jr. and a plea from patients with ALS for access to BrainStorm’s NurOwn.
Second Half Milestones, KalVista’s Surprise Approval, Another RFK Jr. Lawsuit, More
Scroll to top